4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-22-091751
Options or other derivatives
- Director acquired 19,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kalin Katherine Bach Director | 2022-08-13 | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | D: show line 1 in the form |
Loading xslF345X03/tm2223585-1_4seq1.xml…